Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_assertion type Assertion NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_head.
- NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_assertion description "[CD56-positive T-lineage PC-ENKTL tumors (n=8) had more localized disease in the TNM (tumor-node-metastasis) staging and were more often of ?? T-cell origin compared with cases of PC-CD56+PTCL (n=9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_provenance.
- NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_assertion evidence source_evidence_literature NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_provenance.
- NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_assertion SIO_000772 25188863 NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_provenance.
- NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_assertion wasDerivedFrom befree-2016 NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_provenance.
- NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_assertion wasGeneratedBy ECO_0000203 NP1216839.RAV2AsJYGwi8w_Wnpl1K71bfMVYplnOfiGja0zHKy0EME130_provenance.